PER35 Antibody

What criteria should I use when selecting a PER35 antibody for my research?

When selecting a PER35 antibody, prioritize antibodies that have been validated using standardized protocols comparing readouts in knockout cell lines and isogenic parental controls. This validation approach, similar to methods used for characterizing VPS35 antibodies, helps ensure specificity and reliability . Consider the following selection criteria:

• Application compatibility (Western blot, immunoprecipitation, immunofluorescence)

• Clone type (monoclonal vs. polyclonal)

• Host species and potential cross-reactivity issues

• Epitope location and accessibility

• Validation data quality and comprehensiveness

• Literature citations demonstrating successful application

The antibody's performance should be assessed using metrics specific to your intended application, as antibodies may perform excellently in one application but poorly in others .

How do I determine the optimal working concentration for a PER35 antibody?

Determining the optimal working concentration requires systematic titration experiments. Start with the manufacturer's recommended concentration range and then:

• Prepare a dilution series spanning at least one order of magnitude

• Test each dilution under identical experimental conditions

• Evaluate signal-to-noise ratio, specificity, and background for each concentration

• Document the lowest concentration that yields reproducible, specific results

What controls should I include when using PER35 antibodies in my experiments?

Proper controls are critical for interpreting antibody-based experiments:

When possible, utilize genetic controls such as CRISPR/Cas9-generated knockout cell lines, which provide the strongest validation of antibody specificity . For flow cytometry, set quadrant markers based on isotype control antibodies to accurately distinguish positive from negative populations .

What are the best protocols for using PER35 antibodies in immunofluorescence applications?

For optimal immunofluorescence results with PER35 antibodies:

• Fixation: Use 4% paraformaldehyde for 15-20 minutes at room temperature to preserve epitope accessibility while maintaining cellular morphology

• Permeabilization: Apply 0.1-0.5% Triton X-100 for 5-10 minutes (adjust based on subcellular localization of PER35)

• Blocking: Incubate with 5-10% serum from the species of the secondary antibody for 1 hour

• Primary antibody incubation: Apply optimized concentration of PER35 antibody (typically 1-10 μg/mL) for 1-3 hours at room temperature or overnight at 4°C

• Secondary antibody application: Use fluorophore-conjugated secondary antibody at 1:500-1:2000 dilution

• Counterstaining: Apply DAPI (1 μg/mL) to visualize nuclei

• Mounting: Use anti-fade mounting medium to preserve signal

For non-adherent cells, modify the protocol to include centrifugation steps between washes and consider using specialized fixation and permeabilization buffers like those used for intracellular staining in flow cytometry .

How can I optimize Western blot protocols for detecting PER35 with antibodies?

Optimizing Western blot protocols for PER35 detection requires attention to several key factors:

• Sample preparation:

  • Include protease inhibitors to prevent degradation

  • Optimize lysis buffer composition based on PER35's subcellular localization

  • Determine appropriate protein loading amount (typically 10-50 μg total protein)

• Gel electrophoresis:

  • Select appropriate acrylamide percentage based on PER35's molecular weight

  • Include molecular weight markers that span PER35's expected size

• Transfer conditions:

  • Optimize transfer time and voltage for complete transfer of PER35

  • Verify transfer efficiency with reversible staining methods

• Blocking and antibody incubation:

  • Test different blocking agents (5% milk, 5% BSA) to determine optimal signal-to-noise ratio

  • Titrate primary antibody concentration (typically 0.1-1 μg/mL)

  • Optimize incubation time and temperature

• Signal detection:

  • Choose detection method based on expected abundance of PER35

  • Consider enhanced chemiluminescence for moderate expression levels

  • Use fluorescent secondary antibodies for quantitative analysis

When possible, include PER35 knockout or knockdown samples as negative controls to confirm antibody specificity, following validation strategies similar to those used for other antibodies .

What are the recommended protocols for using PER35 antibodies in flow cytometry?

For flow cytometry applications with PER35 antibodies:

• Cell preparation:

  • Use freshly isolated cells when possible

  • Ensure single-cell suspension with viability >90%

  • Fix cells with 2-4% paraformaldehyde if needed

• Surface staining (if applicable):

  • Incubate cells with Fc block to prevent non-specific binding

  • Stain with relevant surface markers (e.g., CD14) to identify cell populations

• Intracellular staining for PER35:

  • Fix and permeabilize cells using a commercial buffer system designed for intracellular epitopes

  • Follow manufacturer's protocol for fixation time and temperature

  • Ensure complete permeabilization for access to intracellular PER35

• Antibody staining:

  • Use approximately 5 μl of conjugated antibody per million cells or 5 μl per 100 μl of whole blood

  • Incubate for 20-30 minutes at room temperature in the dark

  • Titrate the antibody for optimal signal-to-noise ratio

• Controls and analysis:

  • Include isotype controls to set accurate gates

  • Use fluorescence-minus-one (FMO) controls for multicolor panels

  • For indirect staining, include secondary-only controls

For intracellular staining, specialized fixation and permeabilization buffers (such as FlowX FoxP3 Fixation & Permeabilization Buffer Kit) may improve detection of intracellular proteins .

How can I validate the specificity of my PER35 antibody using genetic approaches?

Genetic validation represents the gold standard for confirming antibody specificity:

• CRISPR/Cas9 knockout validation:

  • Generate PER35 knockout cell lines using CRISPR/Cas9 genome editing

  • Compare antibody signals between knockout and parental wild-type cells

  • A specific antibody will show signal in wild-type cells but not in knockout cells

• siRNA/shRNA knockdown validation:

  • Transiently deplete PER35 using targeted siRNA or stably deplete using shRNA

  • Compare antibody signals between knockdown and control (scrambled) cells

  • Specific antibodies will show reduced signal proportional to knockdown efficiency

• Overexpression validation:

  • Transfect cells with PER35 expression vectors

  • Compare antibody signals between transfected and non-transfected cells

  • Specific antibodies will show increased signal in overexpressing cells

• Epitope tagging:

  • Express epitope-tagged PER35 and detect with both PER35 antibody and tag-specific antibody

  • Colocalization confirms epitope recognition

This systematic approach to validation, similar to methods used for VPS35 antibodies , provides strong evidence for antibody specificity and prevents experimental artifacts due to non-specific binding.

What bioinformatic approaches can help predict cross-reactivity of PER35 antibodies?

Bioinformatic analyses can help predict potential cross-reactivity issues:

• Epitope sequence analysis:

  • Identify the exact epitope sequence recognized by the antibody

  • Perform BLAST searches against the proteome to identify proteins with similar sequences

  • Assess sequence conservation across species for cross-species applications

• Structural homology modeling:

  • Generate or obtain structural models of PER35 and related proteins

  • Analyze structural similarities that might contribute to cross-reactivity

  • Identify conformational epitopes that may not be apparent from sequence analysis

• Computational binding affinity prediction:

  • Use biophysics-informed models to predict binding affinities

  • Identify potential binding modes with related proteins

  • Assess the energetic favorability of off-target interactions

• Post-translational modification mapping:

  • Identify potential post-translational modifications that might affect epitope recognition

  • Predict how modifications alter antibody binding

These computational approaches, similar to the biophysics-informed models used for antibody specificity prediction , can guide experimental validation and help select antibodies with minimal cross-reactivity.

How can I quantitatively assess the binding affinity and specificity of PER35 antibodies?

Quantitative assessment of antibody binding characteristics involves several complementary approaches:

• Surface Plasmon Resonance (SPR):

  • Measure association and dissociation rates (ka and kd)

  • Calculate equilibrium dissociation constant (KD)

  • Compare binding kinetics to related proteins to assess specificity

• Enzyme-Linked Immunosorbent Assay (ELISA):

  • Perform dose-response curves with varying antibody concentrations

  • Calculate EC50 values for target and potential cross-reactive proteins

  • Determine specificity index as ratio of EC50 values

• Bio-Layer Interferometry (BLI):

  • Real-time, label-free detection of binding kinetics

  • Determine on/off rates for PER35 and potential cross-reactive proteins

  • Compare affinity profiles across related proteins

• Competitive binding assays:

  • Use labeled reference antibody with known binding characteristics

  • Measure displacement by test antibody

  • Calculate IC50 values to compare binding affinities

These quantitative approaches provide objective metrics for antibody performance, allowing researchers to select optimal antibodies based on specific binding profiles rather than subjective assessments .

How can computational modeling be used to design PER35 antibodies with customized specificity profiles?

Computational modeling represents a cutting-edge approach to antibody design:

• Biophysics-informed modeling approaches:

  • Train models on experimentally selected antibodies

  • Associate distinct binding modes with specific ligands

  • Use these models to predict and generate variants with desired specificity profiles

• Specificity optimization strategies:

  • For highly specific antibodies: minimize binding energy for PER35 while maximizing energy for undesired targets

  • For cross-specific antibodies: jointly minimize binding energy for multiple desired targets

  • Optimize CDR sequences to enhance desired interactions

• Implementation workflow:

  • Generate initial antibody library through phage display experiments

  • Characterize binding profiles through high-throughput sequencing

  • Develop computational models that disentangle binding modes

  • Design novel sequences optimized for desired specificity profiles

  • Validate designed antibodies experimentally

This computational approach enables the design of antibodies with customized binding profiles that may not be achievable through selection-based methods alone, particularly when discriminating between very similar epitopes .

What novel applications of PER35 antibodies are emerging in single-cell analysis?

Single-cell technologies represent a frontier for antibody applications:

• Mass cytometry (CyTOF) applications:

  • Conjugate PER35 antibodies with rare earth metals

  • Integrate into panels of 40+ markers for comprehensive phenotyping

  • Correlate PER35 expression with cellular identity and functional states

• Single-cell proteomics:

  • Use PER35 antibodies in microfluidic-based single-cell Western blotting

  • Incorporate into antibody-based proximity ligation assays

  • Apply in spatial proteomics workflows to maintain tissue context

• CITE-seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing):

  • Conjugate PER35 antibodies with oligonucleotide barcodes

  • Simultaneously measure protein expression and transcriptome in single cells

  • Correlate PER35 protein levels with gene expression profiles

• Spatial biology applications:

  • Use PER35 antibodies in multiplexed immunofluorescence imaging

  • Apply for highly multiplexed imaging mass cytometry

  • Integrate into spatial transcriptomics workflows

These emerging applications allow researchers to study PER35 expression and function with unprecedented resolution and in the context of complex cellular phenotypes and tissue microenvironments.

How can PER35 antibodies be utilized in combination with CRISPR screens for functional genomics?

Integrating antibody-based detection with CRISPR screening creates powerful functional genomics approaches:

• CRISPR activation/interference screens:

  • Use CRISPR activation/interference libraries to modulate gene expression

  • Apply PER35 antibodies to quantify protein levels by flow cytometry

  • Identify genes that regulate PER35 expression or stability

• Arrayed CRISPR screening with antibody readouts:

  • Perform gene editing in arrayed format

  • Use automated immunofluorescence with PER35 antibodies as readout

  • Identify genes affecting PER35 localization, modification, or abundance

• Pooled CRISPR screens with antibody-based sorting:

  • Create pooled CRISPR libraries targeting genes of interest

  • Use PER35 antibodies and FACS to isolate cells with altered PER35 expression

  • Sequence guide RNAs in sorted populations to identify regulators

• Epistasis analysis:

  • Combine CRISPR editing of candidate genes with PER35 antibody detection

  • Map genetic interactions affecting PER35 function

  • Establish position of PER35 in signaling pathways

These approaches enable systematic investigation of genes and pathways regulating PER35 expression, localization, and function, providing insights into its biological role and regulation.

What are common causes of false positive and false negative results when using PER35 antibodies?

Understanding potential sources of error is critical for accurate interpretation:

To distinguish genuine findings from artifacts, always include appropriate positive and negative controls, particularly genetic controls when possible , and verify results using multiple detection methods and antibody clones.

How can I optimize fixation and permeabilization protocols for detecting PER35 in different subcellular compartments?

Fixation and permeabilization must be tailored to the subcellular localization of PER35:

• Cytoplasmic PER35 detection:

  • Fixation: 2-4% paraformaldehyde for 10-15 minutes

  • Permeabilization: 0.1-0.2% Triton X-100 or 0.1% saponin

  • Optimize time and concentration to maintain structural integrity while allowing antibody access

• Nuclear PER35 detection:

  • Fixation: 4% paraformaldehyde for 15-20 minutes

  • Permeabilization: 0.3-0.5% Triton X-100 for enhanced nuclear penetration

  • Consider nuclear isolation protocols for cleaner detection

• Membrane-associated PER35 detection:

  • Fixation: Gentle fixation with 2% paraformaldehyde for 10 minutes

  • Permeabilization: Mild detergents like 0.1% saponin or digitonin

  • Maintain membrane integrity while allowing antibody access

• Method comparison:

  • Test different fixation/permeabilization combinations systematically

  • Document signal intensity, background, and morphology preservation

  • Select protocol that maximizes signal-to-noise ratio while preserving relevant structures

For flow cytometry applications, specialized buffers like FlowX FoxP3 Fixation & Permeabilization Buffer Kit may improve intracellular protein detection , while immunofluorescence microscopy may require different protocols to preserve subcellular architecture.

What strategies can improve signal detection when working with low-abundance PER35 protein?

Detecting low-abundance proteins requires specialized approaches:

• Signal amplification methods:

  • Tyramide signal amplification (TSA): Amplifies signal 10-100 fold

  • Poly-HRP conjugated secondary antibodies: Increases detection sensitivity

  • Tertiary detection systems: Adds additional amplification layer

• Sample enrichment approaches:

  • Immunoprecipitation before Western blotting

  • Cell sorting to isolate high-expressing populations

  • Subcellular fractionation to concentrate target compartments

• Advanced microscopy techniques:

  • Super-resolution microscopy for improved spatial resolution

  • Deconvolution to enhance signal-to-noise ratio

  • Long exposure time with sensitive cameras

• Protein stabilization strategies:

  • Proteasome inhibitors to prevent degradation

  • Phosphatase inhibitors to preserve modifications

  • Optimized extraction buffers to maintain protein integrity

When working with low-abundance proteins, careful optimization of each experimental step is essential, from sample preparation to detection, to maximize sensitivity while maintaining specificity .